Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Im is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2012 - 2015
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2009 - 2012
Albert Einstein College of MedicineClass of 2009
Certifications & Licensure
AZ State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2012 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
ABIMHematology- ABIMInternal Medicine
- ABIMOncology
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsHistone lactylation drives CD8T cell metabolism and function.Deblina Raychaudhuri, Pratishtha Singh, Bidisha Chakraborty, Mercedes Hennessey, Aminah J Tannir
Nature Immunology. 2024-11-01 - 1 citationsGastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host disease.Curtis M Marcoux, Amin M Alousi, Jin Im, Laquisa C Hill, Portia Smallbone
Bone Marrow Transplantation. 2024-11-01 - 1 citationsLong-term outcomes after haploidentical stem cell transplantation for hematologic malignancies.Supawee Saengboon, Stefan Ciurea, Uday Popat, Jeremy Ramdial, Qaiser Bashir
Blood Advances. 2024-06-25
Abstracts/Posters
- Reduced Severe aGVHD and Improved Survival Using Post Transplant Cyclophosphamide/Tacrolimus/Methotrexate Graft Versus Host Disease Prophylaxis in AML Patients Receivi...Jin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantat...Jin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell TransplantationJin S Im, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Developing Novel Therapies Targeting the Tumor Microenvironment of Aggressive Breast CancerApril 3rd, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
